C2W-10292-96270
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 177 / PA
- Registered
- 2021-06-01
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-08
Dose 1 — Pfizer-BioNTech
-
2021-06-01
Registered in v-safe
-
2021-06-01
Dose 2 — Pfizer-BioNTech
-
2021-06-01
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Note: I am entering this information immediately after receiving the second shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-02
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Myalgia — Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tirednessFree text: Lightheadedness (mild) (Note: muscle aching only in left upper arm - injection given in left arm)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-06-29
- 2021-07-06
- 2021-07-13
- 2021-08-31
- 2021-11-30
-
2022-06-03
Survey response — 12 months, dose 2MedDRA: Asthenia, Fatigue, Headache, Loss of personal independence in daily activities, Oropharyngeal pain, Quarantine, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mild Covid in January - sore throat, congestion, mild runny nose, tired, headaches? (Unable to do normal daily activities - next question - primarily because of Covid quarantine restrictions, but also less energy than normal, of course)MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-08 | Pfizer-BioNTech | |
| 2 | 2021-06-01 | Pfizer-BioNTech |
Free text
Release 8 — day 0, dose 2
Systemic reaction (other): Note: I am entering this information immediately after receiving the second shot.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Lightheadedness (mild) (Note: muscle aching only in left upper arm - injection given in left arm)
Release 11 — 12 months, dose 2
Symptoms: Mild Covid in January - sore throat, congestion, mild runny nose, tired, headaches? (Unable to do normal daily activities - next question - primarily because of Covid quarantine restrictions, but also less energy than normal, of course)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release